Subscribe

Main navigation

Home
Conferences
2026 Washington, DC
2026 London
2025 Berlin
2024 Athens
2023 New York City
CME
Spotlight
Studies
Media
About
About SEGM
FAQ
Our Response to the SPLC
Contact
Grant Opportunities
Support

Search results

False Assumptions Behind Youth Gender Transitions

December 30, 2022
Spotlight
A recent publication examines and refutes several key assumptions that underlie an influential “pro-affirmation” paper published by the journal Nature.
Matched fragments:
… gender dysphoria during or after puberty, challenge the notion that a … The Endocrine Society’s protocol (puberty blockers at the earliest stage of …

Pediatric gender affirming care is not evidence-based

May 10, 2025
Studies

Over the last two years there has been a surge in research studies and systematic reviews reporting on the use of puberty blockers and cross-sex hormones as treatment for gender-distressed youth. This makes it difficult for the non-specialist to keep on top of the evidence. The psychiatrist...

Matched fragments:
… for risks and benefits of puberty blockers and gender-affirming … reviews reporting on the use of puberty blockers and cross-sex hormones as …

Informed Consent for Gender-Affirmative Care

March 22, 2022
Spotlight
Trans-identified youth present to clinicians as strongly desiring hormones and surgery. However, this conviction should not be confused with the capacity to carefully consider the consequences of gender transition, argues a recent article about informed consent in gender medicine,...
Matched fragments:
… which entails the use of puberty blockers, cross-sex hormones, and … problems of youth with post-puberty onset of gender …

The American Academy of Pediatrics 2023 Policy Update

August 6, 2023
Spotlight

We welcome the American Academy of Pediatrics (AAP) decision to update treatment recommendations for gender dysphoric youth based on the results of a systematic...

Matched fragments:
… policy for treating minors with puberty blockers, hormones and surgery … adverse effects of puberty blockers and …

[Uncertainties around the current gender care: five problems with the clinical lesson 'Youth with gender incongruence']

November 1, 2023
Studies
The clinical lesson 'Youth with gender incongruence' by Dutch gender clinicians aims to describe Dutch adolescent gender care and its dilemma's. This commentary discusses five serious objections. First, the lesson fails to draw the implications from its acknowledgement of the paucity of evidence:...
Matched fragments:
… of the paucity of evidence: puberty blockers and cross-sex hormones most … not acknowledge the dilemma that puberty blockers may impede, rather …

Evidence review: gender-affirming hormones for children and adolescents with gender dysphoria

January 1, 2020
Studies

In 2020, the UK National Institute for Health and Care Excellence (NICE) undertook two systematic evidence reviews of the use of GnRH agonists (also known as "puberty blockers") and cross-sex hormones as treatments for...

Matched fragments:
… of GnRH agonists (also known as "puberty blockers") and cross-sex hormones as …

Retrospective Cohort Study of Transgender Adolescents at Strasbourg University Hospital

June 26, 2026
Studies
Introduction: Medical care for transgender minors is understudied, largely because these forms of care are relatively recent. The primary objective of this work was to describe the cohort of transgender adolescents who initiated follow-up at the Strasbourg University Hospital before the age of 18,...
Matched fragments:
… of 6% of adolescents received puberty blockers as monotherapy. The mean …

Three decades of ‘Dutch Protocol’ research has not produced reliable evidence

May 30, 2026
Studies
In ‘The Dutch Approach for Transgender Adolescents; Past, Present and Future Perspectives,’ clinicians and researchers from the Center of Expertise on Gender Dysphoria (CEGD) look back at three decades of CEGD research and conclude that, on the basis of these studies, they can now have ‘far more...
Matched fragments:
… more confidence’ in providing puberty blockers, cross-sex hormones, and …

Looking Back on 2024 and Ahead to 2025

December 30, 2024
Spotlight
What has SEGM been up to this year? As we reach the end of 2024, we wanted to look back at this year's major developments in the field of youth gender medicine and look ahead to the challenges and opportunities 2025 presents.
Matched fragments:
… of  binding and tucking ),  puberty blockers, and cross-sex hormones for … and long-term consequences of puberty blockers, hormones, and …

The Cass Review, the “Yale” Report, and the Importance of Keeping Special Interests at Bay

October 22, 2024
Spotlight
McNamara et al 2024's “An Evidence-Based Critique of the Cass Review” alleges that the Cass Review “repeatedly misuses data and violates its own evidentiary standards,” is “rife with misapplications of the scientific method,” and fails to evaluate the evidence "in a neutral and scientifically valid...
Matched fragments:
… unethical," and advocated that puberty blockers, cross-sex hormones and … the Cass Review has done with puberty blockers for the treatment …

Pagination

  • First page « First
  • Previous page ‹
  • …
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • …
  • Next page ›
  • Last page Last »

SEGM is committed to safeguarding scientific integrity through open discourse and collaboration. Researchers and clinicians worldwide must be free to pursue scientific inquiry without censorship or intimidation.

Our Response to the SPLC
FAQs about SEGM
Close

Society for Evidence-Based Gender Medicine

© 2020-2026 SEGM